14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Sep 29, 2023 $6.38 $6.60 $6.15 $6.47 43 422
Sep 28, 2023 $6.24 $6.40 $6.02 $6.22 26 819
Sep 27, 2023 $6.06 $6.52 $5.94 $6.36 29 676
Sep 26, 2023 $6.12 $6.37 $5.95 $6.06 34 832
Sep 25, 2023 $5.94 $6.30 $5.89 $6.14 34 824
Sep 22, 2023 $6.01 $6.23 $5.56 $6.08 138 043
Sep 21, 2023 $6.03 $6.29 $5.87 $6.10 90 321
Sep 20, 2023 $6.50 $6.55 $6.00 $6.19 258 881
Sep 19, 2023 $6.41 $6.74 $6.23 $6.59 65 957
Sep 18, 2023 $7.03 $7.03 $6.43 $6.49 50 296
Sep 15, 2023 $6.95 $7.03 $6.53 $6.96 91 915
Sep 14, 2023 $6.70 $7.06 $6.56 $7.06 52 320
Sep 13, 2023 $6.77 $6.78 $6.58 $6.74 40 895
Sep 12, 2023 $6.68 $6.72 $6.39 $6.72 27 223
Sep 11, 2023 $6.43 $6.69 $6.10 $6.56 43 492
Sep 08, 2023 $6.89 $7.04 $6.36 $6.46 58 829
Sep 07, 2023 $6.75 $6.98 $6.56 $6.96 29 701
Sep 06, 2023 $7.26 $7.26 $6.48 $6.90 90 477
Sep 05, 2023 $7.68 $7.68 $7.15 $7.27 68 659
Sep 01, 2023 $7.68 $7.69 $7.13 $7.68 164 928
Aug 31, 2023 $7.13 $7.66 $6.80 $7.54 56 418
Aug 30, 2023 $6.74 $7.28 $6.70 $7.09 31 279
Aug 29, 2023 $6.52 $7.17 $6.14 $6.74 102 228
Aug 28, 2023 $6.80 $7.01 $6.52 $6.56 28 897
Aug 25, 2023 $6.60 $7.01 $6.60 $6.80 19 041
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT